Nadendla R. Molecular .2023 .Modification-A Strategy in Drug Discovery and Drug Design. Biomedical Journal of Scientific & Technical Research, 52(2) : 43511-22.
Dhudum R,Ganeshpurkar A,Pawar A,Candidates Drug .2024 .Revolutionizing Drug Discovery: A Comprehensive Review of AI Applications. , 3(1) : 148-71.
Myers T. .2021 .Mosby's dictionary of medicine, nursing & health professions. , : 1944-1980.
Li C,Zhang C,Deng R .2019 .Prediction of human pharmacokinetics of antibody-drug conjugates from nonclinical data. Clinical and translational science, 12(5) : 534-44.
Betts A,Keunecke A,van Steeg TJ .2018 .Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: a comparison between human, cynomolgus monkey and hFcRn Tg32 transgenic mouse using a populationmodeling approach. , 14624(5) : 751-64.
Ruiz-Garcia A,Bermejo M,Moss A,Casabo VG .2008 .Pharmacokinetics in drug discovery. Journal of pharmaceutical sciences, 97(2) : 654-90.
Herrera Carranza J. Manual .2003 .de farmacia clínica y atención farmacéutica. , 1(2) : 87-8.
Hashida M. .2020 .Role of pharmacokinetic consideration for the development of drug delivery systems: A historical overview. Advanced drug delivery reviews, 06(1) : 71-82.
Bryant BJ,Knights KM,Rowland A,Darroch S .2019 .Pharmacology for health professionals. , : 156-164.
Siddiqui S,Naqvi GR,Ali H .2021 .Formulation development of directly compressible mebevarine tablets using superdisintegrant: A way to investigate quality atributes, in vitro release kinetics and stability profile. Pakistan Journal of Pharmaceutical Sciences, 34(3) : 915-25.
Choi YH,Han H-K. Nanomedicines YH .2018 .: current status and future perspectives in aspect of drug delivery and pharmacokinetics. Journal of pharmaceutical investigation, 48(1) : 43-60.
Sweetman SC,Martindale C .2020 .Martindale: The complete drug reference. Sweetman SC, : 1692-1778.
Mahmood I. .2021 .Interspecies Scaling of AntibodyDrug Conjugates (ADC) for the Prediction of Human Clearance. Antibodies, 10(1) : 1-13.
Stefano Giordani .2023 .Liposomes characterization for market approval as pharmaceutical products: Analytical methods, guidelines and standardized protocols. Journal of Pharmaceutical and Biomedical Analysis, 115751(30) : 1-12.
Ciociola AA,Cohen LB,Kulkarni P .2013 .How drugs are developed and approved by the FDA: current process and future directions. Official journal of the American College of Gastroenterology| ACG, 407(5) : 620-3.
Wang Y,Xing J,Xu Y .2015 .T modelling for rational drug design. Quarterly reviews of biophysics, 48(4) : 488-515.
Ball K,Bruin G,Escandon E .2022 .Special Section on Pharmacokinetics and ADME of Biological Therapeutics-Minireview Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White Paper. Drug Metab Dispos, 50(6) : 858-66.
Li Y,Meng Q,Yang M .2019 .Current trends in drug metabolism and pharmacokinetics. Acta Pharmaceutica Sinica B, 10(6) : 1113-44.
Gohel MC,Sarvaiya KG,Mehta NR,Soni CD,Vyas VU,Dave RK .2005 .Assessment of similarity factor using different weighting approaches. Dissolution Technologies, 12(4) : 22-7.
Hughes JD,Blagg J,Price DA .2008 .Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorganic & medicinal chemistry letters, 07(17) : 4872-5.
Sheth TS,Acharya F .2021 .Optimizing similarity factor of in vitro drug release profile for development of early stage formulation of drug using linear regression model. Journal of Mathematics in Industry, 11(1) : 1-10.
Yuksel N,Kanık AE,Baykara T. .2000 .Comparison of in vitro dissolution profiles by ANOVAbased, model-dependent and-independent methods. International journal of pharmaceutics, 5173(00) : 00554-8.
Goutelle S,Woillard JB,Neely M,Yamada W .2022 .Nonparametric methods in population pharmacokinetics. The Journal of Clinical Pharmacology, 62(2) : 142-57.
Bonate PL .2005 .Recommended reading in population pharmacokinetic pharmacodynamics. The AAPS journal, 7(37) : E363-E73.
Shirke S,Shewale S,Satpute M. PRODRUG,Sciences M. PRODRUG .2015 .DESIGN: AN OVERVIEW. International Journal of Pharmaceutical, 5(1) : 232-41.
Pal A,Banik BK .2020 .Highly Efficient Prodrugs: Design and Therapeutic Applications (AReview). Oriental Journal of Chemistry, 36(6) : 985-1000.
Khaliq SA,Khan M,Azeem S,Fatima A .2024 .A Narrative Review on Current Development and Future Prospects for the Treatment of Dengue Virus Infection. Liaquat National Journal of Primary Care, 6(2) : 165-73.
Lindsey WT,Olin BR,Hansen RA. Systematic,Review RA. Systematic,Meta-Analysis RA. Systematic,Bentley JP,McGraw-Hill Education JP .2020 .. Aparasu RR, 14 : 151-160.
Alonso-Coello P,Schünemann HJ,Moberg J .2016 .GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. Br Med, 353(1) : 01-10.
Deng C,Liu J,Zhang W. Structural .2022 .modification in anesthetic drug development for prodrugs and soft drugs. Frontiers in Pharmacology, 923353(1) : 1-14.
Oyeneyin O,Ipinloju N,Ojo N,Akerele D .2021 .Structural modification of ibuprofen as new NSAIDs via DFT, molecular docking and pharmacokinetics studies. International Journal of Advances in Engineering and Pure Sciences, 33(4) : 614-26.
Roost C,Lynch SR,Batista PJ,Qu K,Chang HY,Kool ET .2015 .Structure and thermodynamics of N6-methyladenosine in RNA: a springloaded base modification. Journal of the American Chemical Society, 137(5) : 2107-15.
Lobo S,Li H,Farhan N,Yan G .2013 .Evaluation of diclofenac prodrugs for enhancing transdermal delivery. Drug development and industrial pharmacy, 76782(3) : 425-32.
Purushottamachar P,Godbole AM,Gediya LK .2013 .Systematic structure modifications of multitarget prostate cancer drug candidate galeterone to produce novel androgen receptor down-regulating agents as an approach to treatment of advanced prostate cancer. Journal of medicinal chemistry, 56(12) : 4880-98.
Mallareddy JR,Borics A,Keresztes A,Tourwé D,Tóth G .2011 .Design, synthesis, pharmacological evaluation, and structureactivity study of novel endomorphin analogues with multiple structural modifications. Journal of medicinal chemistry, 54(5) : 1462-72.
Chiaberge S,Guglielmetti G,Montanari L .2009 .Investigation of asphaltene chemical structural modification induced by thermal treatments. Energy & fuels, 23(9) : 4486-95.
Lim S-A .2006 .Ethambutol-associated optic neuropathy. Annals-academy of Medicine, 35(4) : 274-8.
Dragulescu-Andrasi A,Rapireddy S,Frezza BM,Gayathri C,Gil RR,Ly DH .2006 .A simple γ- backbone modification preorganizes peptide nucleic acid into a helical structure. Journal of the American Chemical Society, 128(31) : 10258-67.
Napolitano A,Panzella L,Savarese M .2004 .Acid-induced structural modifications of unsaturated fatty acids and phenolic olive oil constituents by nitrite ions: a chemical assessment. , 17(10) : 1329-37.
Baltes E,Coupez R,Giezek H,Voss G,Meyerhoff C .2001 .Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers. Fundamental & Clinical Pharmacology, 00035(4) : 8206-77.
Tambe V,Ditani A,Rajpoot K,Tekade RK,Tekade RK,Gijrat RK .2021 .Pharmacokinetics aspects of structural modifications in drug design and therapy. -12-814425- 1, : 00014-0.
Abbas AM,Nasrallah HH,Aboelmagd A,Anti-Inflammatory Activity .2024 .Docking Study of New Ibuprofen Derivatives. International Journal of Molecular Sciences, 25(6) : 1-22.
Sacha M,Faucon L,Hamon E,Ly I .2018 .Ex vivo transdermal absorption of a liposome formulation of diclofenac. Biomedicine & Pharmacotherapy, 12(1) : 785-90.
Korneev D,Pevneva G,Voronetskaya N. .2021 .Effects of the composition and molecular structure of heavy oil asphaltenes on their reactivity in thermal decomposition processes. Petroleum Chemistry, 61(1) : 152-61.
Mishra MK,Kukal S,Paul PR .2021 .Insights into structural modifications of valproic acid and their pharmacological profile. Molecules, 27(1) : 1-19.
Islam S,Hosen MA,Ahmad S .2022 .Synthesis, antimicrobial, anticancer activities, PASS prediction, molecular docking, molecular dynamics and pharmacokinetic studies of designed methyl α-D-glucopyranoside esters. Journal of Molecular Structure, 13276(1) : 1-16.
Song W,Si S. .2017 .The rare ethambutol-induced optic neuropathy: a case-report and literature review. Medicine, 96(2) : 00000000000058-89.
Padilla MN,Mata-Pérez C,Melguizo M .2016 .In vitro nitro-fatty acid release from Cys-NO2-fatty acid adducts under nitrooxidative conditions. Nitric Oxide, 12(1) : 14-22.
Correia A,Monteiro A,Silva R,Moreira J,Lobo JS,Silva A .2022 .Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders. Advanced Drug Delivery Reviews, 114485(1) : 1-22.
Gao G,Wang Y,Hua H,Li D,Tang C,Biological Activity,Chemistry Synthetic .2021 .. Mar Drugs, 19(7) : 1-30.